Wilbanks Smith & Thomas Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$22.9M Sell
144,847
-1,059
-0.7% -$169K 0.64% 32
2023
Q4
$22.9M Buy
145,906
+7,733
+6% +$1.19M 0.7% 27
2023
Q3
$21.5M Sell
138,173
-4,536
-3% -$748K 0.74% 26
2023
Q2
$23.6M Sell
142,709
-5,007
-3% -$808K 0.78% 29
2023
Q1
$22.9M Buy
147,716
+226
+0.2% +$36.5K 0.8% 29
2022
Q4
$26.1M Buy
147,490
+4,605
+3% +$795K 0.99% 23
2022
Q3
$23.3M Buy
142,885
+2,425
+2% +$410K 1% 20
2022
Q2
$24.9M Buy
140,460
+2,042
+1% +$364K 1.05% 19
2022
Q1
$24.7M Buy
138,418
+3,365
+2% +$573K 0.99% 17
2021
Q4
$23.1M Buy
135,053
+4,215
+3% +$690K 0.8% 20
2021
Q3
$21.1M Buy
130,838
+2,253
+2% +$384K 0.83% 18
2021
Q2
$21.2M Buy
128,585
+3,105
+2% +$514K 0.83% 20
2021
Q1
$20.6M Buy
125,480
+8,062
+7% +$1.3M 0.89% 22
2020
Q4
$18.5M Buy
117,418
+3,806
+3% +$562K 0.87% 21
2020
Q3
$16.9M Buy
113,612
+3,946
+4% +$584K 0.92% 19
2020
Q2
$15.4M Buy
109,666
+3,928
+4% +$572K 0.94% 18
2020
Q1
$13.9M Buy
105,738
+4,668
+5% +$662K 1.03% 19
2019
Q4
$14.7M Buy
101,070
+1,545
+2% +$210K 0.87% 22
2019
Q3
$12.9M Buy
99,525
+922
+0.9% +$121K 0.81% 24
2019
Q2
$13.7M Sell
98,603
-831
-0.8% -$115K 0.88% 22
2019
Q1
$13.9M Buy
99,434
+4,617
+5% +$618K 0.9% 24
2018
Q4
$12.2M Sell
94,817
-818
-0.9% -$114K 0.84% 27
2018
Q3
$13.2M Buy
95,635
+1,882
+2% +$250K 0.8% 26
2018
Q2
$11.4M Sell
93,753
-64
-0.1% -$7.99K 0.91% 21
2018
Q1
$12M Buy
93,817
+16,925
+22% +$2.29M 0.97% 20
2017
Q4
$10.7M Sell
76,892
-372
-0.5% -$51.8K 0.85% 22
2017
Q3
$10M Buy
77,264
+927
+1% +$123K 0.85% 24
2017
Q2
$10.1M Sell
76,337
-1,951
-2% -$249K 0.89% 21
2017
Q1
$9.75M Buy
78,288
+930
+1% +$111K 0.83% 23
2016
Q4
$8.91M Buy
77,358
+14,088
+22% +$1.63M 0.8% 24
2016
Q3
$7.47M Sell
63,270
-13,760
-18% -$1.67M 0.7% 28
2016
Q2
$9.34M Buy
77,030
+14,067
+22% +$1.6M 0.97% 23
2016
Q1
$6.81M Sell
62,963
-368
-0.6% -$38.1K 0.82% 24
2015
Q4
$6.5M Buy
63,331
+12,194
+24% +$1.23M 0.64% 27
2015
Q3
$4.77M Sell
51,137
-12,539
-20% -$1.21M 0.68% 30
2015
Q2
$6.21M Sell
63,676
-2,573
-4% -$258K 0.61% 32
2015
Q1
$6.67M Sell
66,249
-578
-0.9% -$58.8K 0.65% 27
2014
Q4
$6.99M Sell
66,827
-1,556
-2% -$164K 0.71% 26
2014
Q3
$7.29M Buy
68,383
+945
+1% +$98K 0.79% 28
2014
Q2
$7.05M Sell
67,438
-375
-0.6% -$37.9K 0.75% 27
2014
Q1
$6.66M Buy
67,813
+187
+0.3% +$17.3K 0.75% 29
2013
Q4
$6.19M Sell
67,626
-2,890
-4% -$266K 0.74% 29
2013
Q3
$6.11M Buy
70,516
+2,226
+3% +$200K 0.82% 29
2013
Q2
$5.86M Buy
+68,290
New +$5.8M 0.9% 25

Other funds holding JNJ

Wilbanks Smith & Thomas Asset Management's JNJ Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.73% in Q1 2024, selling an estimated $169K and leaving 144,847 shares worth $22.9M. The position accounts for 0.64% of the portfolio, ranked #32.

Wilbanks Smith & Thomas Asset Management first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $26.1M in Q4 2022. 3,849 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Wilbanks Smith & Thomas Asset Management held 144,847 shares of Johnson & Johnson worth $22.9M as of Q1 2024.
  • Wilbanks Smith & Thomas Asset Management sold 1,059 Johnson & Johnson shares in Q1 2024, an estimated $169K.
  • Johnson & Johnson made up 0.64% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #32 holding.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
  • Wilbanks Smith & Thomas Asset Management's Johnson & Johnson position peaked at $26.1M in Q4 2022.
  • 3,849 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.